Clinical Trials List
2025-09-18 - 2028-09-28
Phase II
Recruiting4
ICD-10C15.8
Malignant neoplasm of overlapping sites of esophagus
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9150.8
Malignant neoplasm of other specified part of esophagus
-
Trial Applicant
PAREXEL INTERNATIONAL CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/05/01
Investigators and Locations
Co-Principal Investigator
- Jeng-Shiun Du 無
- Tsung-Jang Yeh 無
- Li-Tzong Chen 無
- Yi-Hsun Chen 無
- 洪國禎 無
- 王閔宏 無
- Wang Yao-Kuang 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 廖亭凱 Division of General Surgery
- 蘇炳睿 Division of General Surgery
- Chia-Jui Yen Division of General Surgery
- 趙盈瑞 Division of General Surgery
- Chien-Jui Huang Division of General Surgery
- Chih-Chieh Yen Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 姜乃榕
- 宮慶雲 Division of Hematology & Oncology
- 邱乃祈
- Tien-Hua Chen Division of Hematology & Oncology
- 方文良
- Chien-An Liu
- 徐博奎 Division of Hematology & Oncology
- 黃國宏 Division of Hematology & Oncology
- 林泰祺
- Yi-Ping Hung
- 郭懿萱 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Wen-Chi Chou
- Yung-Chia Kao
- Shih-Chiang Huang
- 劉耿豪 Division of General Surgery
- Wen-Chi Shen
- Hung-Chih Hsu
- 湯文誠
- Po-Jung Su Division of General Surgery
- Ming-Mo Hou
- Jen-Shi Chen
- 蔡悅如 Division of Ophthalmology
- 李兆偉
- 徐潤德
- 陳建銘
- Tai-Sen Yeh
- 蔡駿逸 Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
10 participants
-
Global
150 participants
